GoldBamboo.com - Knowledge is strong medicine
  

Epidemiology of Gallbladder Sludge & Stones in Pregnancy - Article


  Not Signed In - Sign In / Register






Gallbladder Cancer


Clinical Trial: Epidemiology of Gallbladder Sludge & Stones in Pregnancy

This study is currently recruiting patients.
Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) August 2005

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00131131

Purpose

The specific objective of this project is to study the impact exercise has on gallstone formation during pregnancy when women are at increased risk due to biochemical and physiological alterations.
Condition Intervention Phase
Cholelithiasis
 Behavior: exercise
Phase III

MedlinePlus related topics:  Gallbladder Diseases

Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study

Further Study Details: 
Primary Outcomes: gallbladder ultrasound
Secondary Outcomes: serum insulin and leptin levels
Expected Total Enrollment:  670

Study start: May 2003;  Expected completion: February 2007
Last follow-up: December 2006;  Data entry closure: December 2006

The female gender and multiparity are the two most important positive correlates of cholesterol gallstone disease. Pregnancy represents the period of time when the ‘lithogenic’ pressure on a woman is the highest. Biliary sludge is a precursor stage of gallstones. We studied the etiological factors associated with the development of sludge and stones during pregnancy, and our early results suggest that it is inversely related to physical activity. We also found that being overweight, a known risk factor for gallstone disease, is associated with high blood leptin levels. In addition, the risk associated with high leptin levels is partially mitigated by physical activity.

In order to disentangle the effects of physical activity, leptin and gestational diabetes on gallbladder disease risk, and to understand the mechanisms behind the observed associations, we propose to conduct a randomized controlled trial. This interventional study is a logical extension of our previous observational investigation. Our Specific Aims are:

  1. To evaluate whether an endurance exercise program is associated with lower risk of gallbladder disease in overweight pregnant women.
  2. To evaluate whether an endurance exercise intervention program changes leptin levels in pregnancy among overweight women.
  3. To examine the associations between gallbladder disease incidence and potential causal variables in this prospective trial. These variables include leptin levels, HDL, insulin levels, BMI (as it varies within women classified as overweight), as well as changes in these variables.

Gallstone disease affects 15-20% of adult Americans. Cholecystectomy is one of the most commonly performed operations. The morbidity, and the burden of cost, incurred by gallstones are staggering. Yet there is a dearth of understanding in the epidemiology and the cause of this disease. The results of this investigation should generate new, important and useful insights into the pathogenesis, and provide a rational strategy for the prevention, of this common and costly disease.

Eligibility

Ages Eligible for Study:  18 Years   -   50 Years,  Genders Eligible for Study:  Female

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

Pregnant, over 18, eligible for care at Madigan Army Medical Center -

Exclusion Criteria:

prior gallbladder surgery, non-english speaking, medical reason not to exercise during pregnancy, moving from area within 3 months

-

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00131131

Lorna Imbruglio, RN      (253) 968-3446    LornaI@medicine.washington.edu

Washington
      Madigan Army Medical Center, Tacoma,  Washington,  98431,  United States; Recruiting
Lorna Imbruglio, RN  253-968-3446    LornaI@medicine.washington.edu 
Misty Wood  (253) 968-3446 
Peter Napolitano, MD,  Principal Investigator

Study chairs or principal investigators

Sum P Lee, MD, PhD,  Principal Investigator,  University of Washington   
Shirley Beresford, PhD,  Study Director,  University of Washington School of Publich Health and Community Medicine   

More Information

Study ID Numbers:  DK46890
Last Updated:  August 16, 2005
Record first received:  August 16, 2005
ClinicalTrials.gov Identifier:  NCT00131131
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-23


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Gallbladder Cancer.

October 8, 2008



Page Updated: October 3, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.